Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Other Non Operating Income: 2022-2025

Historic Other Non Operating Income for P3 Health Partners (PIII) over the last 4 years, with Q3 2025 value amounting to -$2.2 million.

  • P3 Health Partners' Other Non Operating Income fell 58539.33% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$676000.0, marking a year-over-year decrease of 14956.01%. This contributed to the annual value of $1.5 million for FY2024, which is 68514.06% up from last year.
  • As of Q3 2025, P3 Health Partners' Other Non Operating Income stood at -$2.2 million, which was down 58539.33% from $583000.0 recorded in Q2 2025.
  • P3 Health Partners' Other Non Operating Income's 5-year high stood at $2.6 million during Q4 2022, with a 5-year trough of -$2.2 million in Q3 2025.
  • For the 4-year period, P3 Health Partners' Other Non Operating Income averaged around $180400.0, with its median value being $213000.0 (2022).
  • The largest annual percentage gain for P3 Health Partners' Other Non Operating Income in the last 5 years was 170000.0% (2023), contrasted with its biggest fall of 207941.18% (2023).
  • P3 Health Partners' Other Non Operating Income (Quarter) stood at $2.6 million in 2022, then crashed by 92.03% to $206000.0 in 2023, then soared by 86.41% to $384000.0 in 2024, then tumbled by 662.5% to -$2.2 million in 2025.
  • Its last three reported values are -$2.2 million in Q3 2025, $583000.0 for Q2 2025, and $318000.0 during Q1 2025.